Has Suzan Fenstermacher received payments from drug or device companies?

Yes. Drug and device makers reported $6,190 in general payments to Suzan Fenstermacher across 327 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Suzan Fenstermacher did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Suzan Fenstermacher come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Suzan Fenstermacher

Physician Assistant · Cortland, NYNPI 1023203247

Payments from drug & device makers

$6,190in general payments, 2019–2025

Across 327 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
GSK$984
Sanofi$685
Regeneron Healthcare Solutions, Inc.$490
Takeda Pharmaceuticals U.S.A., Inc.$455
Novartis$388
plus $2K from 21 others

What the payments were for

Food & beverage$6,174100%
Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	58	$1,260
GSK	85	$984
Sanofi	34	$685
Regeneron Healthcare Solutions, Inc.	25	$490
Takeda Pharmaceuticals U.S.A., Inc.	19	$455
Novartis	16	$388
Biocryst US Sales Co., LLC	11	$266
Amgen	11	$252
Pfizer	11	$208
Optinose US, Inc.	9	$181
CSL Behring	5	$146
Teva Pharmaceuticals USA, Inc.	8	$128
Boehringer Ingelheim	6	$111
Pharming Healthcare, Inc.	4	$96
Lilly USA, LLC	3	$80
Blueprint Medicines Corporation	3	$73
Genentech USA, Inc.	3	$68
AbbVie	2	$51
Aimmune Therapeutics, Inc.	2	$45
Octapharma USA, Inc.	2	$41
Alk-abello, Inc	2	$39
Kaleo, Inc.	2	$36
Bio Products Laboratory USA, Inc.	2	$33
Biohaven Pharmaceutical Holding Company Ltd.	1	$22
Grifols USA, LLC	1	$19
Merck	1	$19
Kedrion Biopharma, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,190 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	42	$34,386
Breo ElliptaFluticasone/Vilanterol	34	$24,518
Breztri AerosphereBudesonide/Glycopyr/Formoterol	18	$19,911
Epinephrine	14	$4,830
Advair DiskusFluticasone Propion/Salmeterol	15	$3,351
Fluticasone Propionate HfaFluticasone Propionate	13	$2,611
Azelastine-FluticasoneAzelastine/Fluticasone	22	$2,606
Mometasone Furoate	38	$2,330
Fluticasone Propionate	50	$1,758
Desloratadine	31	$1,621
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	13	$1,368
Azelastine Hcl	35	$1,235
Levocetirizine Dihydrochloride	90	$1,043
Montelukast Sodium	50	$687
Albuterol Sulfate HfaAlbuterol Sulfate	27	$555

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta	$984	$58,90476 claims
AstraZenecaBreztri Aerosphere	$1,260	$19,91118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Cortland

Henry YuBronx$1M
Michael AsbachAmherst$962K
Janelle BunceJamestown$565K
Kristyl Cuenca-SiskoNew York$478K
Melissa WhiteGarden City$320K
Lawrence HermanHolbrook$315K
Kaitlyn NelsonBrooklyn$289K
Sari KatzGarden City$271K
Julius NwosuBronx$256K
Cameron KiserNew York$225K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →